Intermittent painless meatus hematuria in an elderly man is actually non-muscle invasive bladder cancer

(Disclaimer: This article is for scientific use only, and the information in the following content has been processed to protect patient privacy)
Abstract: Non-muscle invasive bladder cancer is a type of malignant tumor of the bladder that occurs mostly in men over 50 years of age, and the exact etiology is unknown. In this case, the patient presented with intermittent, painless, naked eye visible hematuria and was diagnosed with non-muscle invasive bladder cancer after CT and magnetic resonance imaging. Transurethral bladder tumor electrosurgery and bladder perfusion immunotherapy were promptly adopted, and the patient’s carnal hematuria disappeared and all indexes returned to normal.
Basic information】Male, 70 years old
Disease Type】Non-muscle invasive bladder cancer
Hospital】Tumor Hospital of Fudan University
Date of Consultation】December 2021
Treatment plan】Surgery (transurethral bladder tumor electrosurgery) + BCG bladder infusion immunotherapy + regular review of cystoscopy
Treatment period】Hospitalization for 20 days, outpatient follow-up for 3 months
Treatment effect] The hematuria disappeared and the indexes returned to normal.
I. Initial consultation
The patient’s family accompanied him to the clinic. The patient reported that he had intermittent, painless, full bladder hematuria with no obvious cause 2 months ago, but he did not pay attention to it. After completing magnetic resonance imaging, the results showed that the bladder occupancy was obvious and the possibility of malignant tumor was high, and the patient was judged to be non-muscle invasive bladder cancer.
II. Treatment history
The patient was recommended to be hospitalized immediately for surgery and underwent transurethral bladder tumor electrosurgery to remove the occupancy. After further communication with the family and the patient, a second course of treatment was initiated, followed by bladder perfusion immunotherapy with intravesical BCG infusion. After 20 days of inpatient treatment, the patient improved and could be discharged for close follow-up and rehabilitation.
III. Treatment effect
After surgical treatment, the patient had no special discomfort, no carnal hematuria was seen with the indwelling catheter, and the patient did not show symptoms of preoperative carnal hematuria when the catheter was subsequently removed. Followed by bladder perfusion immunotherapy, no adverse drug reactions were observed and the patient’s clinical symptoms were completely relieved. At the postoperative outpatient follow-up for 3 months, the patient’s sarcohematuria disappeared, no occupancy was seen on imaging, and all indexes returned to normal. 
IV. Notes
As a treating physician, we are very happy to see the patient discharged from the hospital in good health. After discharge, the patient should relax, ensure sleep, combine work and rest, live a regular life, maintain a healthy work and rest, quit smoking and alcohol, exercise moderately, and eat a low salt and low fat diet. According to the doctor’s advice, regular follow-up review of cystoscopy can be done so that if the tumor recurs, it can be detected early and treated accordingly. If you find abnormal color of urine or large amount of foam, you need to seek medical attention and investigate the cause.
V. Personal insight
Bladder cancer is a common malignant tumor of the bladder, which can be divided into non-muscle invasive bladder cancer and muscle invasive bladder cancer according to the depth of infiltration. The cause of this disease is unknown, but it may be related to smoking, exposure to toxic and harmful industrial chemicals, etc. Irregular life and unhealthy lifestyle may also trigger this disease, so try to avoid these risk factors.